| 常用名 | Bamlanivimab | CAS号 | 2423943-37-5 |
|---|---|---|---|
| 价格 | ¥需询单/1g ¥需询单/5g | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and Drug Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab[1]. 物理化学性质: CAS号:2423943-37-5 常用中文名:Bamlanivimab 常用英文名:Bamlanivimab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |